Mit zielgerichteten Therapien neue Perspektiven bei generalisierter Myasthenia gravis

NeuroTransmitter 2026

View at publisher

Authors: Matthias Manych

DOI: 10.1007/s15016-025-4185-7

Cited by: 0

Fields of Study & Subjects

Myasthenia Gravis and Thymoma Peripheral Neuropathies and Disorders Autoimmune Bullous Skin Diseases